Results 151 to 160 of about 1,205,694 (316)

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Radiotherapy delivery error detection with electronic portal imaging device (EPID)-based in vivo dosimetry. [PDF]

Chin Med J (Engl), 2023
Yang X, Geng L, Huang D, Li K, Zhuang H, Cai J, Yang R.   +6 more
europepmc   +1 more source

Technical Report for Egocentric Mistake Detection for the HoloAssist Challenge [PDF]

arXiv
In this report, we address the task of online mistake detection, which is vital in domains like industrial automation and education, where real-time video analysis allows human operators to correct errors as they occur. While previous work focuses on procedural errors involving action order, broader error types must be addressed for real-world use.
arxiv  

Error detection in formal languages

Journal of Computer and System Sciences, 1970
The effects that certain classes of errors have on formal languages are considered from the point of view of preservation of languages under error transformations. This approach is an expansion of an article by Hartmanis and Stearnes [9], in which only the finite error case on regular expressions was considered.An automaton that detects that errors ...
openaire   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Examining the difference in error detection when listening to native and non-native speakers. [PDF]

Q J Exp Psychol (Hove), 2023
Sanders G, de Bruin A.
europepmc   +1 more source

Performance evaluation of different TCP error detection and congestion control strategies over a wireless link [PDF]

, 2000
Tanja Lang, Daniel Floreani
openalex   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

BeppoSAXObservations of GRB 980425: Detection of the Prompt Event and Monitoring of the Error Box [PDF]

, 2000
E. Pian, L. Amati, L. A. Antonelli, R. C. Butler, E. Costa, G. Cusumano, John Danziger, M. Feroci, F. Fiore, F. Frontera, P. Giommi, N. Masetti, J. M. Muller, L. Nicastro, T. Oosterbroek, M. Orlandini, Alan Owens, E. Palazzi, A. N. Parmar, L. Piro, J. J. M. in ’t Zand, A. J. Castro‐Tirado, Alessandro Coletta, D. Dal Fiume, S. Del Sordo, J. Heise, P. Soffitta, V. Torroni   +27 more
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source